Immunotherapies have shown to be a great promise in treating pediatric cancers, although clinical successes in solid tumors have been limited. Among other things this is because current studies are hampered by the lack of knowledge on the composition and function of the pediatric cancer immune microenvironment. As an expert in single-cell readouts, with a wet-lab and dry-lab background in molecular pathology and tumor immunology, that is where I come in. Next to my day-to-day facility-work, I’m heavily involved in projects aiming to map the immune microenvironment of pediatric solid tumors. My ultimate goal is to foster the development of (novel) immunotherapeutic strategies to treat pediatric cancers. To achieve this, I’m collaborating with several research groups from the Princess Maxima Center and UMCU.
Phone 088 97 27 686